Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: Effects of fatty acids and cyclooxygenase inhibitors

No abstract is available for this paper.

• Publication year

  1994

• Venue

  International Journal of Cancer

• Publication date

  1994-04-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/ijc.2910570208PMID 7512536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification and characterization of a fatty acid binding protein from human prostatic tissue

  1993cited by this paper
• Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease.

  1991cited by this paper
• Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines

  1991cited by this paper
• Fish consumption and breast cancer risk: an ecological study.

  1989cited by this paper
• Growth-inhibition effects of oleic acid, linoleic acid, and their methyl esters on transplanted tumors in mice.

  1989cited by this paper
• The Mediterranean diet: protective or simply non-toxic?

  1989cited by this paper
• Cancer in Alaskan Indians, Eskimos, and Aleuts, 1969-83: implications for etiology and control.

  1989cited by this paper
• Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate, and ovarian tumors.

  1988cited by this paper
• The effects of dietary omega-3 fatty acids on the DU-145 transplantable human prostatic tumor.

  1987cited by this paper
• Relevance of fatty acids and eicosanoids to clinical and preventive medicine.

  1986cited by this paper
• Epidemiological study of prostatic cancer by matched‐pair analysis

  1986cited by this paper
• Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins.

  1985cited by this paper
• Prostaglandins, steroids and human mammary cancer.

  1985cited by this paper
• Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man.

  1985cited by this paper
• Diet, obesity, and risk of fatal prostate cancer.

  1984cited by this paper
• Potential role of platelets in the pathogenesis of tumor metastasis.

  1984cited by this paper
• Metabolic epidemiology of prostatic cancer

  1984cited by this paper
• Inositol trisphosphate, a novel second messenger in cellular signal transduction

  1984cited by this paper
• Potential role of platelets in the pathogenesis of tumor metastasis

  1984cited by this paper
• Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis.

  1983cited by this paper
• Quantitation and early kinetics of inositol lipid changes induced by vasopressin in isolated and cultured hepatocytes.

  1983cited by this paper
• Diet in the epidemiology of carcinoma of the prostate gland.

  1983cited by this paper
• Extraction and thin-layer chromatography of arachidonic acid metabolites.

  1982cited by this paper
• Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediates.

  1982cited by this paper
• Effect of fatty acid modification of cultured hepatoma cells on susceptibility to natural killer cells.

  1982cited by this paper
• Prostaglandins and cancer

  1982cited by this paper
• Prostaglandins as mediators of paraneoplastic syndromes: review and up-date.

  1981cited by this paper
• Arachidonic acid transformation and tumor production.

  1981cited by this paper
• Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid.

  1980cited by this paper
• Review: prostaglandins and cancer.

  1980cited by this paper
• Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells.

  1980cited by this paper
• Epidemiologic study of prostatic cancer: preliminary report.

  1977cited by this paper
• Prostaglandin: increased production by renal cell carcinoma.

  1977cited by this paper
• Prostaglandin: increased production by renal cell carcinoma.

  1977cited by this paper
• Studies in the epidemiology of prostatic cancer: expanded sampling.

  1977cited by this paper
• Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.

  1975cited by this paper
• Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells

  1975cited by this paper
• Diet and mortality from malignant disease in 32 countries.

  1974cited by this paper
• Effects of indomethacin on Moloney sarcoma virus-induced tumors.

  1974cited by this paper
• Diet and mortality from malignant disease in 32 countries.

  1974cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper
• the characterization of tissue

  year unknowncited by this paper

• Integrated transcriptomics, proteomics, and pathway enrichment analysis in the spleen and skin of chickens reveal tissue-specific roles for the Marek’s disease virus conserved herpesvirus protein kinase

  2025cites this paper
• Exosomal Lipids in Cancer Progression and Metastasis

  2025cites this paper
• Phospholipase A2 expression in prostate cancer as a biomarker of good prognosis: A comprehensive study in patients with long follow-up

  2024cites this paper
• Effect of aspirin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from randomized controlled trials and real-world studies

  2023cites this paper
• 5-hydroxyeicosatetraenoic acid controls androgen reduction in diverse types of human epithelial cells.

  2022cites this paper
• The role of the metabolite cargo of extracellular vesicles in tumor progression

  2021cites this paper
• Clinical significance of EPHX2 deregulation in prostate cancer

  2020cites this paper
• Seasonal expressions of prostaglandin E synthases and receptors in the prostate of the wild ground squirrel (Spermophilus dauricus).

  2020cites this paper
• International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1–4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions

  2020cites this paper
• Inflammatory markers in cancer: Potential resources.

  2020cites this paper
• Functional expression of human prostaglandin E2 receptor 4 (EP4) in E. coli and characterization of the binding property of EP4 with Gα proteins

  2020cites this paper
• Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2

  2020cites this paper
• Combined maternal and post‐weaning high fat diet inhibits male offspring's prostate cancer tumorigenesis in transgenic adenocarcinoma of mouse prostate model

  2019cites this paper
• Hepatocarcinoma Discrimination by Ratiometric Lipid Profiles Using Tip-Contact Sampling/Ionization Mass Spectrometry.

  2019cites this paper
• Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer

  2019cites this paper
• Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression

  2018cites this paper
• Intracrine prostaglandin E2 pro‐tumoral actions in prostate epithelial cells originate from non‐canonical pathways

  2018cites this paper
• Eicosanoids in prostate cancer

  2018cites this paper
• MSD-MAP: A Network-Based Systems Biology Platform for Predicting Disease-Metabolite Links.

  2017cites this paper
• Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms

  2017cites this paper
• Predictive value of cyclooxygenase-2 over expression for identifying prostate cancer from benign prostatic hyperplasia in prostate biopsy specimens.

  2016cites this paper
• Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy

  2015cites this paper
• Fatty Acid Composition of Human Periprostatic Adipose Tissue from Argentine Patients and Its Relationship to Prostate Cancer and Benign Prostatic Hyperplasia

  2015cites this paper
• Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells

  2015cites this paper
• AKT and cytosolic phospholipase A2α form a positive loop in prostate cancer cells.

  2015cites this paper
• Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A2α via AKT in prostate cancer cells

  2014cites this paper
• Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France

  2014cites this paper
• Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE Study

  2014cites this paper
• Investigation of Key Genes associated with Prostate Cancer using RNA-Seq Data

  2014cites this paper
• Significance of cytosolic phospholipase A2-alpha in PTEN-null/mutated prostate cancer cells

  2014influential citation
• Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1.

  2013cites this paper
• TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway.

  2013cites this paper
• Prostaglandin receptor EP 3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells

  2013cites this paper
• Cytosolic phospholipase A2α sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells.

  2013cites this paper
• Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells.

  2013cites this paper
• Arachidonic acid metabolism in human prostate cancer

  2012cites this paper
• Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids

  2012cites this paper
• Development, Molecular Biology, and Physiology of the Prostate

  2012cites this paper
• Omega-3 fatty acids in health and disease.

  2011cites this paper
• Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.

  2011cites this paper
• ERG oncogene modulates prostaglandin signaling in prostate cancer cells

  2011cites this paper
• Modulation of PGE2-induced EP4 expression on snail signaling and the impact on epithelial-mesenchymal transition: significance of EP4 antagonism.

  2011cites this paper
• Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk

  2011influential citation
• Gene Expression and Biological Pathways in Tissue of Men with Prostate Cancer in a Randomized Clinical Trial of Lycopene and Fish Oil Supplementation

  2011cites this paper
• Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Risk: A Population-Based Nested Case-Control Study

  2011cites this paper
• Cafeteria Diet Increases Prostaglandin E2 Levels in Rat Prostate, Kidney and Testis

  2010cites this paper
• Pathogenic Role of Cyclooxygenase-2 in Cancer

  2010cites this paper
• Pharmacological Targeting of the Integrated Protein Kinase B, Phosphatase and Tensin Homolog Deleted on Chromosome 10, and Transforming Growth Factor-β Pathways in Prostate Cancer

  2009cites this paper
• Group IIA phospholipase A2 as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease‐specific mortality

  2009cites this paper
• Efecto del D-004 administrado durante 60 d sobre la hiperplasia de próstata inducida por la inyección de testosterona en ratas

  2009cites this paper
• Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms.

  2008cites this paper
• Roles of Eicosanoids in Prostate Cancer.

  2008cites this paper
• Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.

  2008cites this paper
• PGE2 and LTB4 tissue levels in benign and cancerous prostates.

  2008cites this paper
• Prostate Cancer Cell Growth: Stimulatory Role of Neurotensin And Mechanism of Inhibition by Flavonoids as Related to Protein Kinase C

  2008cites this paper
• Polyunsaturated fatty acids and prostate cancer metastasis

  2008cites this paper
• Role of Prostaglandin Synthesis and Cyclooxygenase-2 in Prostate Cancer and Metastasis

  2008cites this paper
• Régulation de l'homéostasie des androgènes et des dérivés des acides gras bioactifs dans la prostate humaine par les UDP-glucuronosyltransférases (UGT)2B

  2008influential citation
• Blood and Prostate Cancer Risk A Prospective Study of Polyunsaturated Fatty Acid Levels in Updated

  2007cites this paper
• Award Number: W81XWH-06-1-0242 TITLE: Prostate Cancer Cell Growth: Stimulatory Role of Neurotensin and Mechanism of Inhibition by Flavonoids as Related to Protein Kinase C PRINCIPAL INVESTIGATOR:

  2007cites this paper
• Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer.

  2007cites this paper
• Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer.

  2007cites this paper
• Can dietary intervention alter prostate cancer progression

  2007cites this paper
• Do Omega-3 Dietary Fatty Acids Lower Prostate Cancer Risk? A Review of the Literature

  2007cites this paper
• A Prospective Study of Polyunsaturated Fatty Acid Levels in Blood and Prostate Cancer Risk

  2007cites this paper
• Exisulind in Combination with Celecoxib Modulates Epidermal Growth Factor Receptor, Cyclooxygenase-2, and Cyclin D1 against Prostate Carcinogenesis: In vivo Evidence

  2007cites this paper
• Lifestyle during and after cancer treatment.

  2007cites this paper
• Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer

  2007cites this paper
• COX-2 Inhibition: A Possible Role in the Management of Prostate Cancer?

  2007cites this paper
• The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis.

  2006cites this paper
• Involvement of arachidonic acid metabolism and EGF receptor in neurotensin-induced prostate cancer PC3 cell growth.

  2006cites this paper
• The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis.

  2006cites this paper
• Regulation of neurotensin receptor function by the arachidonic acid-lipoxygenase pathway in prostate cancer PC3 cells.

  2006cites this paper
• Adenocarcina of the mouse prostate growth inhibition by celecoxib: Downregulation of transcription factors involved in COX‐2 inhibition

  2006cites this paper
• Cyclooxygenase-2 억제제와 Prostaglandin E 2 수용체 효현제가 Endothelin 계에 미치는 영향 The Effects of Selective Cyclooxygenase-2 Inhibitor and Prostaglandin E 2 Receptor Agonists on the Endothelin Axis of Prostate Cancer Cells

  2006cites this paper
• The Crucial Role of Cyclooxygenase-2 in Osteopontin-Induced Protein Kinase C α/c-Src/IκB Kinase α/β–Dependent Prostate Tumor Progression and Angiogenesis

  2006cites this paper
• Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population

  2006cites this paper
• The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs.

  2006cites this paper
• The Effects of Selective Cyclooxygenase-2 Inhibitor and Prostaglandin E2 Receptor Agonists on the Endothelin Axis of Prostate Cancer Cells

  2006cites this paper
• Oral acute and subchronic toxicity of D-004, a lipid extract from Roystonea regia fruits, in rats.

  2005cites this paper
• Factors InvolvedinCOX-2 Inhibition

  2005cites this paper
• Dietary advice combined with a salicylate, mineral and vitamin supplement (CV247) has some tumour static properties: a phase II study

  2005cites this paper
• Role of diet in prostate cancer development and progression.

  2005cites this paper
• Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos.

  2005cites this paper
• Conception, synthèse et évaluation pharmacologique de γ-carbolines, inhibiteurs potentiels de 5-lipoxygénase et de cyclooxygénases

  2005cites this paper
• 15-lipoxygenase metabolites of gamma-linolenic acid/eicosapentaenoic acid suppress growth and arachidonic acid metabolism in human prostatic adenocarcinoma cells: possible implications of dietary fatty acids.

  2005cites this paper
• A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.

  2005cites this paper
• Preclinical and clinical investigations as an approach to rational phytotherapy in prostate diseases

  2004cites this paper
• Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion

  2004cites this paper
• In Vitro Proliferation of Fibrosarcoma Cells Depends on Intact Functions of Lipoxygenases and Cytochrome P-450-Monooxygenase

  2004cites this paper
• Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy

  2004cites this paper
• Reishi or Ling Zhi (Ganoderma lucidum) = Solomon P. Wasser

  2004cites this paper
• Dietary n – 6 and n – 3 Polyunsaturated Fatty Acids and Prostate Cancer Risk: A Review of Epidemiological and Experimental Evidence

  2004cites this paper
• Omega-3 (n-3) Fatty Acids in Health and Disease: Part 1—Cardiovascular Disease and Cancer

  2004cites this paper
• Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer.

  2004cites this paper
• Analysis of vitamin D‐regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays

  2004cites this paper
• Inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationale.

  2004cites this paper
• Effect of Isocaloric Low-Fat Diet on Prostate Cancer Xenograft Progression to Androgen Independence

  2004cites this paper
• Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase.

  2004cites this paper
• Antiinflammatories and Chemoprevention

  2004cites this paper